Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Compass Therapeutics Inc. - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
CMPX
Nasdaq
8731
https://www.compasstherapeutics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Compass Therapeutics Inc.
Compass Therapeutics Receives FDA Fast Track Designation for the Investigation of CTX-009 in Combination with Paclitaxel for the Treatment of Patients with Metastatic or Locally Advanced Biliary Tract Tumors That Have Been Previously Treated
- Apr 25th, 2024 12:00 pm
Compass Therapeutics Announces First Patient Dosed in the Phase 1 Study of CTX-8371 in Patients with Solid Tumors
- Apr 16th, 2024 12:00 pm
Compass Therapeutics Announces Poster Presentations at the Cholangiocarcinoma Foundation 2024 Annual Conference
- Apr 12th, 2024 12:00 pm
Compass Therapeutics to Participate in the Stifel Targeted Oncology Days
- Apr 10th, 2024 12:00 pm
Compass Therapeutics Presents Data Demonstrating Elimination of MHC Class I Negative Tumors in In Vivo Models at the 2024 American Association for Cancer Research (AACR) Annual Meeting
- Apr 9th, 2024 4:00 pm
Compass Therapeutics Reports 2023 Financial Results and Provides Corporate Update
- Mar 21st, 2024 1:00 pm
Compass Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
- Feb 29th, 2024 1:00 pm
Compass Therapeutics Announces Publication of CTX-8371 Preclinical Data in OncoImmunology, its Bispecific Antibody Checkpoint Inhibitor, now Advancing to First-in-Human Clinical Trial
- Feb 28th, 2024 1:00 pm
Compass Therapeutics Provides Corporate Update
- Jan 5th, 2024 1:00 pm
Compass Therapeutics Insider Ups Holding During Year
- Dec 12th, 2023 12:27 pm
Compass Therapeutics Inc (CMPX) Reports Q3 2023 Financial Results and Corporate Developments
- Nov 9th, 2023 1:17 pm
Compass Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
- Nov 9th, 2023 12:30 pm
Compass Therapeutics to Participate in Upcoming Investor Events
- Nov 7th, 2023 1:00 pm
Compass Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
- Aug 3rd, 2023 12:00 pm
Compass Therapeutics to be Added to the Russell 2000® and Russell 3000® Indexes
- Jun 22nd, 2023 8:05 pm
Compass Therapeutics Reports First Quarter Financial Results and Provides Corporate Update
- May 4th, 2023 12:30 pm
Scroll